Page 17 - Journal of Special Operations Medicine - Winter 2014
P. 17

Tactical Hemorrhage Control Case Studies
                     Using a Point-of-Care Mechanical Direct Pressure Device



                                  Andrew W. Kirkpatrick, CD, MD, MHSC, FRCSC, FACS;
                                                 Jessica Lynn McKee, MSc








              ABSTRACT
              In 2012, a new hemorrhage control device entered the   take time to apply, making them difficult to use in Care
              market, and by May 2013, the iTClamp  50 had ac-   Under Fire (CUF) scenarios, where there is currently an
                                                  ™
              quired US Food and Drug Administration approval. The   unmet need to achieve rapid hemostasis. These findings
              authors describe the use of the iTClamp 50 and present   suggest that outside of traumatic amputation (which al-
              two case studies in which the iTClamp 50 was success-  ways requires tourniquet application), other lifesaving
              fully used in the military environment to control poten-  hemorrhage control options should be examined.
              tially fatal hemorrhage.
                                                                 In 2012, a new hemorrhage control device entered the
              Keywords: hemorrhage control, prehospital care, iTClamp 50  market, and by May 2013, the iTClamp 50 had acquired
                                                                 US Food and Drug Administration approval. Preclinical
                                                                 studies have demonstrated the safety and effectiveness
              Introduction
                                                                 of the iTClamp 50 to control bleeding. In a lethal swine
              Exsanguination has not only been established as respon-  bleeding model (femoral artery injury), the iTClamp 50
              sible for 50% to 90% of battlefield fatalities but also   was 100% effective at controlling bleeding.  Treatment
                                                                                                      22
              been shown to be the leading cause of potentially pre-  with the iTClamp 50 also improved survival rate, survival
              ventable deaths worldwide. 1–3  Traditional methods to   time, and external blood loss. A preclinical reperfused ca-
              stop the bleeding such as packing and tourniquets, while   daver study demonstrated that the iTClamp 50 was effec-
              important modalities, are not without their issues. The   tive at controlling blood loss from multiple compressible
              efficacy of packing has been substantially improved with   zones, including the scalp, neck, groin, and extremities. 23
              hemostatic dressings ; however, this skill is still user de-  This model involved reperfusing the cadaver with sterile
                               4
              pendent.  The safety and effectiveness of tourniquet use   water using a peristaltic pump to mimic blood flow. The
                     5
              are also well documented in literature, especially when   function of the iTClamp 50 was unaffected by movement
              applied in the military prehospital setting, before the on-  of the cadaver. In both studies, there was no evidence of
              set of shock and even for extended periods of time. 6–18    skin tearing or damage due to the device. Current data
              Limb exsanguination has dropped from 9% in the Viet-  also support its use in CUF given that the iTClamp can
              nam conflict to 2% currently due to the implementation   be (1) applied through two layers of uniform, (2) applied
              of tourniquet use in battle, with the Israeli Defense Force   in 5 to 9 seconds while wearing wet gloves, (3) applied by
              reporting 0% life loss to limb exsanguination. 14  novice users with no instruction, and (4) created no tissue
                                                                 damage after 6 hours of device application.
              Tourniquets are, however, not without their reported
              issues. Application of a tourniquet is not a benign in-
              tervention, and the individual applying the device must   Technique: Control difficult-to-control
              be well trained in order for the tourniquet to be effec-  hemorrhage with the iTClamp 50 Mechanical
              tive. 14,19  Recent studies have shown that tourniquets   Direct Pressure Device
              exposed to the combat environment have decreased ef-  1.  Open the package by pulling forward on the outer
              ficacy and increased breakage.  In addition, tourniquets   tabs.
                                        20
              applied  in  the  field  can  be  ineffective.  A  recent  study   2.  Remove the device from the package by lifting up,
              demonstrated that 83% of tourniquets in place when   taking care not to close the device until it has been
              the patient arrived at a forward surgical team had a pal-  applied to the wound.
              pable distal pulse. In the case of major arterial injuries,
              only 35% of patients presented with an effective arterial   NOTE: Device seal will hold device open until broken
              tourniquet.  Also, tourniquets and hemostatic dressings   (Figure 1).
                       21


                                                               7
   12   13   14   15   16   17   18   19   20   21   22